Drug Sponsors

KCI expands operations in Brazil

Friday, September 14, 2012 11:44 AM

KCI, a global medical technology company, is expanding existing operations in Brazil.

More... »

Report: Healthcare, regulatory and reimbursement landscape - Mexico

Friday, September 14, 2012 11:28 AM

Industry analysis specialist GlobalData has released its new report, Healthcare, Regulatory and Reimbursement Landscape – Mexico, which identifies the key trends in the Mexican healthcare market, as well as providing insights on the demographic, regulatory and reimbursement landscape, and the healthcare infrastructure of Mexico.

More... »

Pfizer, Hisun launch joint venture Hisun-Pfizer Pharmaceuticals

Friday, September 14, 2012 11:13 AM

Pfizer, the world's largest research-based pharmaceutical company, and Zhejiang Hisun Pharmaceuticals, a Chinese pharmaceutical company, have launched their joint venture Hisun-Pfizer Pharmaceuticals, to develop, manufacture and commercialize off-patent pharmaceutical products in China and global markets.

More... »

Vascular Pharma completes $16M equity financing, signs agreement with Janssen

Thursday, September 13, 2012 08:00 AM

Vascular Pharmaceuticals, a drug discovery company developing a product to treat patients with complications arising from diabetes, has successfully completed a $16 million Series A equity financing.

More... »

StemCells awarded $20M from CIRM for Alzheimer's program

Wednesday, September 12, 2012 10:52 AM

The California Institute for Regenerative Medicine (CIRM), which awards grants and loans for stem cell research, has approved an award to StemCells, a cell-based therapeutics company based in Newark, Calif., for up to $20 million under CIRM's Disease Team Therapy Development Award program (RFA 10-05).

More... »

Takeda completes its Russian pharmaceutical manufacturing facility

Wednesday, September 12, 2012 09:39 AM

Takeda Pharmaceutical International, a Zurich-based wholly owned subsidiary of Takeda Pharmaceutical Company, has completed construction at its pharmaceutical manufacturing facility in Yaroslavl, Russia.

More... »

Insmed names Will Lewis president and CEO

Tuesday, September 11, 2012 11:19 AM

Monmouth Junction, N.J.-based Insmed, a biopharmaceutical company focused on developing novel inhalation therapeutics for patients suffering from serious orphan lung diseases, has appointed Will Lewis president and CEO, effective immediately.

More... »

ViroPharma expands in PA, creates 151 jobs

Tuesday, September 11, 2012 08:00 AM

ViroPharma, a biopharmaceutical company that focuses on rare diseases, will expand its operations in Exton, Penn., and create 151 new, high-paying jobs.

More... »

Annovation Biopharma raises $8M to develop novel anesthetics

Tuesday, September 11, 2012 08:00 AM

Annovation Biopharma, a biotech focused on safer therapies for anesthesia, has raised $8 million in a Series A financing led by Atlas Venture, Partners Innovation Fund (PIF) and new strategic investor The Medicines Company. 

More... »

Abbott, Astellas collaborate on CMV vaccine trial

Monday, September 10, 2012 11:03 AM

Abbott has signed an agreement to collaborate with Astellas Pharma Global Development in a phase III clinical trial for ASP0113 (TransVax), an investigational vaccine licensed from Vical for preventing cytomegalovirus (CMV) reactivation in transplant patients.

More... »